On Oct 02, major Wall Street analysts update their ratings for $Shattuck Labs (STTK.US)$, with price targets ranging from $2 to $2.
Citi analyst Yigal Nochomovitz downgrades to a hold rating, and adjusts the target price from $8 to $2.
Evercore analyst Jonathan Miller maintains with a buy rating.
TD Cowen analyst Marc Frahm maintains with a buy rating.
Needham analyst Gil Blum downgrades to a hold rating.
H.C. Wainwright analyst Joseph Pantginis downgrades to a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Shattuck Labs (STTK.US)$'s main analysts recently are as follows:
Despite earlier 'promising' Phase 1 responses for SL-172154 combined with azacitidine in TP53 mutant acute myeloid leukemia and higher-risk myelodysplastic syndromes, it was revealed that these did not lead to a significant improvement in overall survival compared to established azacitidine monotherapy benchmarks, thus not justifying further development. With SL-325 being at least a year away from clinical trials and unlikely to contribute to near-term share value, a reassessment of the stock's outlook was suggested.
Here are the latest investment ratings and price targets for $Shattuck Labs (STTK.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
